Mitigating overdiagnosis and overtreatment in breast cancer: what is the role of the pathologist?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 24628451)

Published in Arch Pathol Lab Med on March 14, 2014

Authors

Benjamin C Calhoun1, Chad A Livasy

Author Affiliations

1: From the Department of Pathology, Carolinas Medical Center, Charlotte, North Carolina (Drs Calhoun and Livasy); and the Department of Pathology, University of North Carolina, Chapel Hill (Dr Livasy). Dr Calhoun is now with the Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio.

Articles by these authors

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA (2006) 24.01

Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin Cancer Res (2003) 1.61

High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Mod Pathol (2005) 1.57

Histological characteristics of singleton placentas delivered before the 28th week of gestation. Pathology (2008) 1.56

Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. Breast Cancer Res Treat (2004) 1.49

Characterization of chorioamnionitis in 2nd-trimester C-section placentas and correlation with microorganism recovery from subamniotic tissues. Pediatr Dev Pathol (2008) 1.45

FAK overexpression and p53 mutations are highly correlated in human breast cancer. Int J Cancer (2009) 1.35

Molecular characterization of human breast tumor vascular cells. Am J Pathol (2008) 1.32

The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study. Breast Cancer Res (2005) 1.14

Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions. Exp Mol Pathol (2007) 1.01

Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts. Int J Radiat Oncol Biol Phys (2010) 0.93

Feasibility of breast preserving therapy with single fraction in situ radiotherapy delivered intraoperatively. Ann Surg Oncol (2007) 0.91

Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation. Exp Mol Pathol (2013) 0.86

Effect of breast compression on lesion characteristic visibility with diffraction-enhanced imaging. Acad Radiol (2009) 0.86

Cosmetic outcomes for accelerated partial breast irradiation before surgical excision of early-stage breast cancer using single-dose intraoperative radiotherapy. Int J Radiat Oncol Biol Phys (2010) 0.82

Local control following single-dose intraoperative radiotherapy prior to surgical excision of early-stage breast cancer. Ann Surg Oncol (2011) 0.81

Overexpression of the receptor tyrosine kinase Tie-1 intracellular domain in breast cancer. Tumour Biol (2003) 0.78

Phase I study and biomarker analysis of lapatinib and concurrent radiation for locally advanced breast cancer. Oncologist (2012) 0.78

Use of the ThinPrep method in bile duct brushings: analysis of morphologic parameters associated with malignancy and determination of interobserver reliability. Diagn Cytopathol (2008) 0.77

Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma. Gynecol Oncol (2004) 0.75